Combination therapy with pioglitazone/exenatide improves beta‐cell function and produces superior glycaemic control compared with basal/bolus insulin in poorly controlled type 2 diabetes: A 3‐ year follow‐up of the Qatar study
Year: 2020
Type: article
Study design: Clinical Trial
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.14153
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3045571047
